Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Libo Xu

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The EMBO Journal|August 28, 2019
ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalizationFei Li, Zhong Deng, Ling Zhang, et al.
Nature Communications|March 29, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.
Journal of Medicinal Chemistry|June 11, 2009
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volumeJohn J Acton, Taro E Akiyama, Ching H Chang, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The EMBO Journal|August 28, 2019
ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalizationFei Li, Zhong Deng, Ling Zhang, et al.
Nature Communications|March 29, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenanceFei Li, Yizhe Wang, Inah Hwang, et al.
Journal of Medicinal Chemistry|June 11, 2009
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volumeJohn J Acton, Taro E Akiyama, Ching H Chang, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2017
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes MellitusJiayi Xu, Songnian Lin, Robert W Myers, et al.
Pageof 8